Uses of evolutionary theory in the human genome project

Annual Review of Ecology and Systematics

Volumn 30, Issue , 1999, Pages 23-49

  Templeton, Alan R ^a  

^a WASHINGTON UNIVERSITY   (United States)

Author keywords

Complex traits; Gene trees; Genetic architecture; Genetic disease; Population structure

Indexed keywords

EID: 0033385991     PISSN: 00664162     EISSN: None     Source Type: Journal    
DOI: 10.1146/annurev.ecolsys.30.1.23     Document Type: Article

References (169)

1. Albert SM, Gurland B, Maestre G, Jacobs DM, Stern Y, et al. 1995 ApoE genotype influences functional status among elderly without dementia. Am. J. Med. Genet. 60:583-87
2. Allan CM, Walker D, Segrest JP, Taylor JM. 1995. Identification and characterization of a new human gene (ApoC4) in the apolipoprotein E, C-I, and C-II gene locus. Genomics 28:291-300
3. Angelicheva D, Calafell F, Savov A, Jordanova A, Kufardjieva A, et al. 1997. Cystic fibrosis mutations and associated haplotypes in Bulgaria: a comparative population genetic study. Hum. Genet. 99: 513-20
4. Berg K. 1990. Risk factor variability and coronary heart-disease. Acta Geneticae Medicae Et Gemellologiae 39:15-24
5. Bindon JR, Baker PT. 1997. Bergmann's rule and the thrifty genotype. Am. J. Phys. Anthropol. 104:201-10
6. Boerwinkle E, Ellsworth DL, Hallman DM, Biddinger A. 1996. Genetic analysis of atherosclerosis: a research paradigm for the common chronic diseases. Hum. Mol. Genet. 5:1405-10
7. Boletini E, Svobodova M, Divoky V, Baysal E, Curuk MA, et al. 1994. Sicklecell-anemia, sickle-cell beta-thalassemia, and thalassemia major in Albania-characterization of mutations. Hum. Genet. 93:182-87
8. Cai XG, Fallin D, Stanton J, Scibelli P, Duara R, et al. 1997. ApoE is linked to Alzheimer's disease in a large pedigree. Am. J. Med. Genet. 74:365-69
9. Cardon LR, Smith SD, Fulker DW, Kimberling WJ, Pennington BF, et al. 1994. Quantitative trait locus for reading disability on chromosome 6. Science 266:276-79
10. Chartier-Harlin M, Parfitt M, Legrain S, Pérez-Tur J, Brousseau T, et al. 1994. Apolipoprotein E, ε4 allele as a major risk factor for sporadic early and late-onset forms of Alzheimer's disease: analysis of the 19q13.2 chromosomal region. Human Mol. Genet. 3:569-74
11. Cheverud JM, Routman EJ. 1995. Epistasis and its contribution to genetic variance components. Genetics 139:1455-61
12. Cho JH, Nicolae DL, Gold LH, Fields CT, Labuda MC, et al. 1998. Identification of novel susceptibility loci for inflammatory bowel disease on chromosomes Iq, 3q, and 4q: evidence for epistasis between 1p and Ibd1. Proc. Natl. Acad. Sci. USA 95:7502-7
13. Clair DS, Rennie M, Slorach E, Norrman J, Yates C, et al. 1995. Apolipoprotein E epsilon-4 allele is a risk factor for familial and sporadic presenile Alzheimer's disease in both homozygote and heterozygote carriers. J. Med. Genet. 32:642-44
14. Clark AG, Weiss KM, Nickerson DA, Taylor SL, Buchanan A, et al. 1998. Haplotype structure and population genetic inferences from nucleotide sequence variation in human lipoprotein lipase. Am. J. Hum. Genet. 63:595-612
15. Cloninger CR, Vaneerdewegh P, Goate A, Edenberg HJ, Blangero J, et al. 1998. Anxiety proneness linked to epistatic loci in genome scan of human personality traits. Am. J. Med. Genet. 81:313-17
16. Collins FS, Guyer MS, Chakravarti A. 1997. Variations on a theme: cataloging human DNA sequence variation. Science 278:1580-81
17. Collins FS, Patrinos A, Jordan E, Chakravarti A, Gesteland R, et al. 1998. New goals for the US human genome project-1998-2003. Science 282:682-89
18. Comuzzie AG, Allison DB. 1998. The search for human obesity genes. Science 280:1374-77
19. Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, et al. 1993. Gene dose of Apoliprotein E type 4 allele and the risk of Alzheiraer's disease in late onset families. Science 261:921-23
20. Cornelis F, Faure S, Martinez M, Prudhomme JF, Fritz P, et al. 1998. New susceptibility locus for rheumatoid arthritis suggested by a genome-wide linkage study. Proc. Natl. Acad. Sci. USA 95:10746-50
21. Crandall KA. 1994. Intraspecific cladogram estimation: accuracy at higher levels of divergence. Syst. Biol. 43:222-35
22. Crandall KA, Templeton AR. 1993. Empirical tests of some predictions from coalescent theory with applications to intraspecific phylogeny reconstruction. Genetics 134:959-69
23. Crow TJ. 1997. Current status of linkage for schizophrenia - polygenes of vanishingly small effect or multiple false positives. Am. J. Med. Genet. 74:99-103
24. Cummings AM, Robertson FW. 1984. Polymorphism at the Apoprotein-E locus in relation to risk of coronary disease. Clinical Genet. 25:310-13
25. Czeizel A. 1989. Application of DNA analysis in diagnosis and control of human diseases. Biol. Zentrabl. 108:295-301
26. Davidson B. 1998. Corporate profile Genaissance Pharmaceuticals. Genet. Engin. News 18:41,62
27. Davies JL, Kawaguchi Y, Bennett ST, Copeman JB, Cordell HJ, et al. 1994. A genome-wide search for human type 1 diabetes susceptibility genes. Nature 371:130-36
28. de la Chapelle A, Wright FA. 1998. Linkage disequilibrium mapping in isolated populations: the example of Finland revisited. Proc. Natl. Acad. Sci. USA 95:12416-23
29. Diamond JM. 1992. Diabetes running wild. Nature 357:362-63
30. Eaves LJ. 1994. Effect of genetic architecture on the power of human linkage studies to resolve the contribution of quantitative traitloci. Heredity 72:175-92
31. El-Hazmi M 1990. Beta globin gene haplotypes in the Saudi sickle-cell-anemia patients. Hum. Hered. 40:177-86
32. Enserink M. 1998. Human genetics - opponents criticize Iceland's database. Science 282:859
33. Fenster CB, Galloway LF, Chao L. 1997 Epistasis and its consequences for the evolution of natural populations. Trends Evol. Ecol. 12:282-86
34. Fisher RA. 1930. The Genetical Theory of Natural Selection. Oxford: Clarendon
35. Flatz G. 1992. Lactase deficiency biologic and medical aspects of the adult human lactase polymorphism. In Genetic Basis of Common Diseases, ed. RA King, JI Rotter, AG Motulsky, pp. 305-25. Oxford: Oxford Univ. Press
36. Ford D, Easton DF, Stratton M, Narod S, Goldgar D, et al. 1998. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. Am. J. Hum. Genet. 62:676-89
37. Frankel WN, Schork NJ. 1996. Who's afraid of epistasis? Nat. Genet. 14:371-73
38. Friedlander Y, Berry EM, Eisenberg S, Stein Y, Leitersdorf E. 1995. Plasma lipids and lipoproteins response to a dietary challenge:analysis of four candidate genes. Clin. Genet. 47:1-12
39. Ginns EI, Jean PS, Philibert RA, Galdzicka M, Damschroder-Williams P, et al. 1998. A genome-wide search for chromosomal loci linked to mental health wellness in relatives at high risk for bipolar affective disorder among the Old Order Amish. Proc. Natl. Acad. Sci. USA 95:15531-36
40. Gloria-Bottini F, Borgiani P, Amante A, Lucarelli P, Bottini E. 1995. Genetic interactions and the environment: a study of ADA and ACP1 systems in the Sardinian population. Hum. Hered. 45:129-34
41. Gulcher J, Stefansson K. 1998. Population genomics laying the groundwork for genetic disease modeling and targeting. Clin. Chem. Lab. Med. 36:523-27
42. Gusella JF, Wexler NS, Conneally PM, Naylor SL, Anderson MA, et al. 1983. A polymorphic DNA marker genetically linked to Huntington's disease. Nature 306:324-28
43. Hallman DM, Boerwinkle E, Saha N, Sandholzer S, Menzel HJ, et al. 1991. The apolipoprotein E polymorphism: a comparison of allele frequencies and effects in nine populations. Am. J. Hum. Genet. 49:338-49
44. Hallman DM, Visvikis S, Steinmetz J, Boerwinkle E. 1994. The effect of variation in the apolipoprotein B gene on plasmid lipid and apolipoprotein B levels. I. A likelihood-based approach to cladistic analysis. Ann. Hum. Genet. 58:35-64
45. Harris H. 1966. Enzyme polymorphisms in man. Proc. R. Soc. Lond. B 164:298-310
46. Haviland MB, Retard C, Kessling AM, Davignon J, Sing CF. 1991. An application of cladistics to the low density lipoprotein receptor (LDLR) gene to identify functional mutations that influence lipid and lipoprotein variation among familial hypercholesterolemia (FH) patients with a 10 kb deletion. Am. J. Hum. Genet. 49 (Suppl):471
47. Haviland MB, Ferrell RE, Sing CF. 1997. Association between common alleles of the low-density lipoprotein receptor gene region and interindividual variation in plasma lipid and apolipoprotein levels in a population-based sample from Rochester, Minnesota. Hum. Genet. 99:108-14
48. Haviland MB, Kessling AM, Davignon J, Sing CF. 1991. Estimation of Hardy-Weinberg and pairwise disequilibrium in the apolipoprotein AI-CIII-AIV gene cluster [published erratum appears in Am. J. Hum. Genet. 1992 Dec; 51(6): 1457]. Am. J. Hum. Genet. 49:350-65
49. Haviland MB, Kessling AM, Davignon J, Sing CF. 1995. Cladistic analysis of the apolipoprotein AI-CIII-AIV gene cluster using a healthy French Canadian sample. I. Haploid analysis. Ann. Hum. Genet. 59:211-31
50. Heizmann C, Kirehgessner T, Kwiterovich PO, Ladias JA, Derby C, et al. 1991. DNA polymorphism haplotypes of the human lipoprotein-lipase gene: possible association with high-density-lipoprotein levels. Hum. Genet. 86:578-84
51. Hill AVS, Motulsky AG. 1999. Genetic variation and human disease: the role of natural selection. In Evolution in Health and Disease, ed. SC Stearns, pp. 50-61. Oxford: Oxford Univ. Press
52. Hill AVS, Sanchez-Mazas A, Barbujani G, Dunston G, Excoffier L, et al. 1999. Human genetic variation and its impact on public health and medicine. In Evolution in Health and Disease, ed. SC Stearns, pp. 50-61. Oxford:Oxford Univ. Press
53. Hofmann S, Jaksch M, Bezold R, Mertens S, Aholt S, et al. 1997. Population genetics and disease susceptibility: characterization of Central European haplogroups by mtDNA gene mutations, correlation with D loop variants and association with disease. Human Mol. Genet. 6:1835-46
54. Jeunemaitre X, Inoue I, Williams C, Charru A, Tichet J, et al. 1997. Haplotypes of angiotensinogen in essential hypertension. Am. J. Hum. Genet. 60:1448-60
55. Jones PA, Rideout WMd, Shen JC, Spruck CH, Tsai YC. 1992. Methylation, mutation and cancer. BioEssays 14:33-36
56. Kamboh MI. 1995. Apolipoprotein E polymorphism and susceptibility to Alzheimer's disease. Hum. Biol. 67:195-215
57. Kamboh MI, Sanghera DK, Aston CE, Bunker CH, Hamman RF, et al. 1997. Gender-specific nonrandom association between the alpha-I-antichymotrypsin and apolipoprotein E polymorphisms in the general population and its implication for the risk of Alzheimer's-disease. Gen. Epidemiol. 14:169-80
58. Kamboh MI, Sanghera DK, Ferrell RE, Dekosky ST. 1995. ApoE*-4 associated Alzheimer's disease risk is modified by alpha-I-antichymotrypsin polymorphism. Nat. Genet. 10:486-88
59. Keavney B, McKenzie CA, Connell JMC, Julier C, Ratcliffe PJ, et al. 1998. Measured haplotype analysis of the angiotensin-I converting enzyme gene. Human Mol. Genet. 7:1745-51
60. Kleyn PW, Vesell ES. 1998. Genetic variation as a guide to drug development. Science 281:1820-21
61. Klitz W, Stephens JC, Grote M, Carrington M. 1995. Discordant patterns of linkage disequilibrium of the peptide-transporter loci within the HLA class II region. Am. J. Hum. Genet. 57:1436-44
62. Ko YL, Ko YS, Wu SM, Teng MS, Chen FR, et al. 1997. Interaction between obesity and genetic polymorphisms in the apolipoprotein CIII gene and lipoprotein lipase gene on the risk of hypertriglyceridemia in Chinese. Hum. Genet. 100:327-33
63. Krawczak M, Cooper DN. 1991. Gene deletions causing human genetic disease: mechanisms of mutagenesis and the role of the local DNA sequence environment. Hum. Genet. 86:425-41
64. Krawczak M, Reitsma PH, Cooper DN. 1995. The mutational demography of protein C deficiency. Hum. Genet. 96:142-46
65. Krushkal J, Xiong MM, Ferrell R, Sing CF, Turner ST, et al. 1998. Linkage and association of adrenergic and dopamine receptor genes in the distal portion of the long arm of chromosome 5 with systolic blood pressure variation. Human Mol. Genet. 7:1379-83
66. Lande R. 1983. The response to selection on major and minor mutations affecting a metrical trait. Heredity 50:47-65
67. Lander ES, Schork NJ. 1994. Genetic dissestion of complex traits. Science 265:2037-48
68. Lannfelt L, Lilius L, Nastase M, Viitanen M, Fratiglioni L, et al. 1994. Lack of association between apolipoprotein-E allele epsilon-4 and sporadic Alzheimer's disease. NeuroScience Letters 169:175-78
69. Lehmann DJ, Johnston C, Smith AD. 1997. Synergy between the genes for butyrylcholinesterase K variant and apolipoprotein ∈4 in late-onset confirmed Alzheimer's-disease. Hum. Mol. Genet. 6: 1933-36
70. Lendon CL, Martinez A, Behrens IM, Kosik KS, Madrigal L, et al. 1997. E280a Ps-1 mutation causes Alzheimer's-disease but age of onset is not modified by ApoE alleles. Hum. Mutation 10:186-95
71. Levo A, Partanen J. 1997. Mutation-haplotype analysis of steroid 2I-hydroxylase (Cyp21) deficiency in Finland: implications for the population history of defective alleles. Hum. Genet. 99:488-97
72. Levy G. 1998. Predicting effective drug concentrations for individual patients. Determinants of pharmacodynamic variability Clin. Pharmacokinetics 34:323-33
73. Li W, Nei M. 1974. Stable linkage disequilibrium without epistasis in subdivided populations. Theor. Pop. Biol. 6:173-83
74. Litt M, Jorde LB. 1986. Linkage disequilibria between pairs of loci within a highly polymorphic region of chromosome 2q. Am. J. Hum. Genet. 39:166-78
75. Liu L, Forsell C, Lilius L, Axelman K, Corder EH, et al. 1996. Allelic association but only weak evidence for linkage to the apolipoprotein E locus in late-onset Swedish Alzheimer families. Am. J. Med. Genet. 67:306-11
76. Lobos EA, Rudnick CH, Watson MS, Isenberg KE. 1989. Linkage disequilibrium study of RFLPs detected at the human muscle nicotinic acetylcholine receptor subunit genes. Am. J. Hum. Genet. 44:522-33
77. Lucarini N, Nicotra M, Gloria-Bottini F, Borgiani P, Amante A, et al. 1995. Interaction between ABO blood groups and ADA genetic polymorphism during intrauterine life. A comparative analysis of couples with habitual abortion and normal puerperae delivering a live-born infant. Hum. Genet. 96:527-31
78. Lucotte G, Visvikis S, Leiningermuler B, David F, Berriche S, et al. 1994. Association of apolipoprotein E allele epsilon-4 with late-onset sporadic Alzheimer's disease. Am. J. Med. Genet. 54:286-88
79. Ludwig EH, Borecki IB, Ellison RC, Folsom AR, Heiss G, et al. 1997. Associations between candidate loci angiotensin-converting enzyme and angiotensinogen with coronary heart disease and myocardial infarction - the NHLBI Family Heart Study. Ann. Epidemiol. 7:3-12
80. 1-antichymotrysin and apolipoprotein E promote assembly of Alzheimer β-protein into filaments. Nature 372:92-94
81. Magewu AN, Jones PA. 1994. Ubiquitous and tenacious methylation of the CpG site in codon 248 of the p53 gene may explain its frequent appearance as a mutational hot spot in human cancer. Mol. Cell. Biol. 14:4225-32
82. Malone KE, Daling JR, Thompson JD, Obrien CA, Francisco LV, et al. 1998. BRCA1 mutations and breast cancer in the general population:analyses in women before age 35 years and in women before age 45 years with first-degree family history. JAMA: J. Am. Med. Assoc. 279:922-29
83. Marshall A. 1997. Laying the foundations for personalized medicines. Nat. Biotech. 15:954-57
84. Matsumoto T, Imamura O, Yamabe Y, Kuromitsu J, Tokutake Y, et al. 1997. Mutation and haplotype analyses of the Werner's-syndrome gene based on its genomic structure: genetic epidemiology in the Japanese population. Hum. Genet. 100:123-30
85. Mayr E. 1974. The challenge of diversity. Taxon 23:3-9
86. McClearn GE, Johansson B, Berg S, Pedersen NL, Ahern F, et al. 1997. Substantial genetic influence on cognitive abilities in twins 80 or more years old. Science 276:1560-63
87. Meyer UA. 1999. Medically relevant genetic variation of drug effects. In Evolution in Health and Disease, ed. SC Stearns, pp. 41-49. Oxford: Oxford Univ. Press
88. Morahan G, Huang D, Tait BD, Colman PG, Harrison LC. 1996. Markers on distal chromosome 2q linked to insulin-dependent diabetes mellitus. Science 272:1811-13
89. Morgan K, Morgan L, Carpenter K, Lowe J, Lam L, et al. 1997. Microsatellite polymorphism of the alpha(I)-antichymotrypsin gene locus associated with sporadic Alzheimer'sdisease. Hum. Genet. 99:27-31
90. Motolsky AG. 1957. Drug reactions enzymes, and biochemical genetics. J. Am. Med. Assoc. 165:835-37
91. Nakagawa H, Koyama K, Miyoshi Y, Ando H, Baba S, et al. 1998. Nine novel germline mutations of STKII in ten families with Peutz-Jeghers-Syndrome. Hum. Genet. 103:168-72
92. Nakauchi Y, Suehiro T, Yamamoto M, Yasuoka N, Arii K, et al. 1996. Significance of angiotensin I-converting enzyme and angiotensin II type 1 receptor gene polymorphisms as risk factors for coronary heart disease. Atherosclerosis 125:161-69
93. Nathan BP, Bellosta S, Sanan DA, Weisgraber KH, Mahley RW, et al. 1994. Differential effects of apolipoproteins E3 and E4 on neuronal growth in vitro. Science 264:850-52
94. Neel JV. 1962. Diabetes mellitus: a "thrifty genotype" rendered detrimental by "progress". Am. J. Hum. Genet. 14:353-62
95. Neel JV, Weder AB, Julius S. 1998. Type n diabetes, essential hypertension, and obesity as "syndromes of impaired genetic homeostasis": the "thrifty genotype" enters the 21st century. Perspect. Biol. Med. 42:44-74
96. Nelson MR, Kardia SLR, Ferrell RE, Sing CF. 1998. A combinatorial optimization approach to identify multilocus genotypic classes associated with quantitative trait variability. Presented at Annu. Meet. Am. Soc. Hum. Genet., 48th, Denver
97. Nesse RM, Williams GC. 1998. Evolution and the origins of disease. Sci. Am. Nov.:86-93
98. Newman B, Mu H, Butler LM, Millikan RC, Moorman PG, et al. 1998. Frequency of breast cancer attributable to BRCA1 in a population-based series of American women. J. Am. Med. Assoc. 279:915-21
99. Nickerson DA, Taylor SL, Weiss KM, Clark AG, Hutchinson RG, et al. 1998. DNA sequence diversity in a 9.7-kb region of the human lipoprotein lipase gene. Nat. Genet. 19:233-40
100. Okuizumi K, Onodera O, Namba Y, Ikeda K, Yamamoto T, et al. 1995. Genetic association of the very low density lipoprotein (VLDL) receptor gene with sporadic Alzheimer's disease. Nat. Genet. 11:207-9
101. Oner C, Dimovski AJ, Olivieri NF, Schiliro G, Codrington JF, et al. 1992. Beta-S haplotypes in various world populations. Hum. Genet. 89:99-104
102. Peacock RE, Temple A, Gudnason V, Rosseneu M, Humphries SE. 1997. Variation at the lipoprotein lipase and apolipoprotein AI-CIII gene loci are associated with fasting lipid and lipoprotein traits in a population sample from Iceland: interaction between genotype, gender, and smoking status. Gen. Epidemiol. 14:265-82
103. Pedersen JC, Berg K. 1990. Gene-gene interaction between the low-density-lipoprotein receptor and apolipoprotein-E loci affects lipid levels. Clinical Genet. 38:287-94
104. Pedersen JD, Berg K. 1989. Interaction between Low-Density Lipoprotein Receptor (LDLR) and Apolipoprotein-E (ApoE) alleles contributes to normal variation in lipid level. Clinical Genet. 35:331-37
105. Pereztur J, Campion D, Martinez M, Brice A, Tardieu S, et al. 1995. Evidence for apolipoprotein E epsilon-4 association in early-onset Alzheimer's patients with late-onset relatives. Am. J. Med. Genet. 60:550-53
106. Pickering L. 1998. Perkin-Elmer and Incyte to map the human genome. Genet. Engin. News 18:18, 41, 51
107. Pillay TS, Langlois WJ, Olefsky JM. 1995. The genetics of non-insulin-dependent diabetes mellitus. Adv. Genet. 32: 51-98
108. Poduslo SE, Riggs D, Schwankhaus J, Osborne A, Crawford F, et al. 1995. Association of apolipoprotein E but not B with Alzheimer's disease. Hum. Genet. 96:597-600
109. Porkka KV, Taimela S, Kontula K, Lehtimaki T, Aaltosetala K, et al. 1994. Variability gene effects of DNA polymorphisms at the ApoB, ApoAI/CIII and ApoE loci on serum-lipids:the cardiovascular risk in young Finns study. Clin. Genet. 45:113-21
110. Rahman N, Stratton MR The Genetics of breast cancer susceptibility. Annu. Rev. Genet. 32:95-121
111. Reddy PH, Modell B. 1996. Reproductive behaviour and natural selection for the sickle gene in the Baiga tribe of Central India-the role of social parenting. Ann. Hum. Genet. 60:231-36
112. Rideout WMd, Coetzee GA, Olumi AF, Jones PA. 1990. 5-Methylcytosine as an endogenous mutagen in the human LDL receptor and p53 gene. Science 249:1288-90
113. Routman EJ, Cheverud JM. 1997. Gene effects on a quantitative trait: two-locus epistatic effects measured at microsatellite markers and at estimated QTL. Evolution. 51:1654-62
114. Sandbrink R, Hartmann T, Masters CL, Beyreuther K. 1996. Genes contributing to Alzheimer's disease. Mol. Psychol. 1:27-40
115. Sanghera DK, Aston CE, Saha N, Kamboh MI. 1999. DNA polymorphisms in two paraoxonase genes (PONI and PON2) are associated with the risk of coronary heart disease. Am. J. Hum. Genet. 62:36-44
116. Schiliro G, Spena M, Giambelluca E, Maggio A. 1990. Sickle haemoglobin-pathies in Sicily. Am. J. Hematol. 33:81-85
117. Schmalhausen II. 1949. Factors of Evolution. Philadelphia: Blakiston Company. 327 pp.
118. Schmutte C, Jones PA. 1998. Involvement of DNA methylation in human carcinogenesis. Biol. Chem. 379:377-88
119. Schork NJ, Cardon LR, Xu X. 1998. The future of genetic epidemiology. Trends Genet. 14:266-72
120. Schull WJ, Annas GJ, Arnheim N, Blangero J, Chakravarti A, et al. 1997. Evaluating Human Genetic Diversity. Washington, DC: Natl. Acad. 91 pp.
121. Sheffield VC, Stone EM, Carmi R. 1998. Use of isolated inbred human populations for identification of disease genes. Trends Genet. 14:391-96
122. Sing CF, Boerwinkle EA. 1987. Genetic architecture of inter-individual variability in apolipoprotein, lipoprotein and lipid phenotypes. Ciba Found. Symp. 130:99-127
123. Sing CF, Davignon J. 1985. Role of the Apolipoprotein E polymorphism in determining normal plasma lipid and lipoprotein variation. Am. J. Hum. Genet. 37:268-85
124. Sing CF, Haviland MB, Reilly SL. 1996. Genetic architecture of common multifactorial diseases. In Variation in the Human Genome, ed. G Cardew, pp. 211-32. Chichester: Wiley
125. Sing CF, Haviland MB, Templeton AR, Reilly SL. 1995. Alternative genetic strategies for predicting risk of atherosclerosis. In Atherosclerosis X. Excerpta Medica. International Congress Series, ed. FP Woodford, J Davignoa, AD Sniderman, pp. 638-44. Amsterdam: Elsevier Sci. B. V.
126. Sing CF, Haviland MB, Templeton AR, Zerba KE, Reilly SL. 1992. Biological complexity and strategies for finding DNA variations responsible for inter-individual variation in risk of a common chronic disease, coronary artery disease. Ann. Med. 24:539-47
127. Sing CF, Haviland MB, Zerba KE, Templeton AR. 1992. Application of cladistics to the analysis of genotype-phenotype relationships. Eur. J. Epidemiol. 8:3-9
128. Sing CF, Moll PP. 1990. Genetics of atherosclerosis. Annu. Rev. Genet. 24: 171-88
129. Sing CF, Orr JD. 1976. Analysis of genetic and environmental sources of variation in serum cholesterol in Tecumseh, Michigan. III. Identification of genetic effects using 12 polymorphic genetic blood marker systems. Am. J. Hum. Genet. 28:453-64
130. Sinsheimer RG. 1969. The prospect of designed genetic change. Engin. Sci. 32:8-13
131. Stengard JH, Weiss KM, Sing CF. 1998. An ecological study of association between coronary heart disease mortality rates in men and the relative frequencies of common allelic variations in the gene coding for Apolipoprotein E. Hum. Genet. 103:234-41
132. Stengard JH, Zerba KE, Pekkanen J, Ehnholm C, Nissinen A, et al. 1995. Apolipoprotein E polymorphism predicts death from coronary heart disease in a longitudinal study of elderly Finnish men. Circulation 91:265-69
133. Stephens JC, Briscoe D, O'Brien SJ. 1994. Mapping by admixture linkage disequilibrium in human populations: limits and guidelines. Am. J. Hum. Genet. 55:809-24
134. Strittmatter WJ, Weisgraber KH, Goedert M, Saunders AM, Huang D, et al. 1994. Hypothesis-microtubule instability and paired helical filament formation in the Alzheimer disease brain are related to apolipoprotein E genotype. Exp. Neuro. 125:163-71
135. Templeton AR. 1982. Genetic architectures of speciation. In Mechanisms of Speciation, ed. C Barigozzi, pp. 105-21. New York: Liss
136. Templeton AR. 1987. The general relationship between average effect and average excess. Genet. Res. 49:69-70
137. Templeton AR. 1995. A cladistic analysis of phenotypic associations with haplotypes inferred from restriction endonuclease mapping or DNA sequencing. V. Analysis of case/control sampling designs: Alzheimer's disease and the Apoprotein E locus. Genetics 140:403-9
138. Templeton AR. 1996. Cladistic approaches to identifying determinants of variability in multifactorial phenotypes and the evolutionary significance of variation in the human genome. In Variation in the Human Genome, ed. G Cardew, pp. 259-83. Chichester: Wiley
139. Templeton AR. 1998. Linkage mapping versus the candidate gene approach. Proceedings of The 6th World Congress on Genetics Applied to Livestock Production 26:175-82
140. Templeton AR. 1999. Epistasis and complex traits. In Epistasis and the Evolutionary Process, ed. M Wade, E Brodie III, J Wolf. Oxford: Oxford Univ. Press. In press
141. Templeton AR, Boerwinkle E, Sing CF. 1987. A cladistic analysis of phenotypic associations with haplotypes inferred from restriction endonuclease mapping. I. Basic theory and an analysis of Alcohol Dehydrogenase activity in Drosophilaz. Genetics 117:343-51
142. Templeton AR, Clark AG, Weiss KM, Nickerson DA, Boerwinkle E, Sing CF. 1999. Recombinational and mutational hotspots within the human Lipoprotein Lipase gene. Am. J. Hum. Genet. In press
143. Templeton AR, Crandall KA, Sing CF. 1992. A cladistic analysis of phenotypic associations with haplotypes inferred from restriction endonuclease mapping and DNA sequence data. III. Cladogram estimation. Genetics 132:619-33
144. Templeton AR, Sing CF. 1993. A cladistic analysis of phenotypic associations with haplotypes inferred from restriction endonuclease mapping. IV. Nested analyses with cladogram uncertainty and recombination. Genetics 134:659-69
145. Templeton AR, Sing CF, Brokaw B. 1976. The unit of selection in Drosophila mercatorum. I. The interaction of selection and meiosis in parthenogenetic strains. Genetics 82:349-76
146. Templeton AR, Sing CF, Kessling A, Humphries S. 1988. A cladistic analysis of phenotypic associations with haplotypes inferred from restriction endonuclease mapping. II. The analysis of natural populations. Genetics 120:1145-54
147. Thomas AE, Green FR, Lamlum H, Humphries SE. 1995. The association of combined alpha and beta fibrinogen genotype on plasma fibrinogen levels in smokers and non-smokers. J. Med. Genet. 32:585-89
148. Thompson EA, Deeb S, Walker D, Motulsky AG. 1988. The detection of linkage disequilibrium between closely linked markers:RFLPs at the AI-CIII apolipoprotein genes. Am. J. Hum. Genet. 42:113-24
149. Todd JA. 1995. Genetic analysis of type I diabetes using whole genome approaches. Proc. Natl. Acad. Sci. USA 92:8560-65
150. Todorova A, Danieli GA. 1997. Large majority of single-nucleotide mutations along the dystrophin gene can be explained by more than one mechanism of mutagenesis. Hum. Mut. 9:537-47
151. Tvrdik T, Marcus S, Hou SM, Falt S, Noori P, et al. 1998. Molecular characterization of two deletion events involving ALU-sequences, one novel base substitution and two tentative hotspot mutations in the Hypoxanthine Phosphoribosyltransferase (HPRT) gene in five patients with Lesch-Nyhan-Syndrome. Hum. Genet. 103:311-18
152. Valdes AM, McWeeney S, Thomson G. 1997. HLA class II DR-DQ amino acids and insulin-dependent diabetes mellitus:application of the haplotype method. Am. J. Hum. Genet. 60:717-28
153. Valdes AM, Thomson G. 1997. Detecting disease predisposing variants: the haplotype method. Am. J. Hum. Genet. 60:703-16
154. Virtaneva K, Damato E, Miao IM, Koskiniemi M, Norio R, et al. 1997. Unstable mini satellite expansion causing recessively inherited Myoclonus Epilepsy, EPM1. Nat. Genet. 15:393-96
155. Wade MJ. 1996. Adaptation in subdivided populations: kin selection and interdemic selection. In Adaptation, pp. 381-405. New York: Academic Press
156. Wade MJ, Goodnight CJ. 1991. Wright's shifting balance theory: an experimental study. Science 253:1015-18
157. Wade MJ, Griesemer JR. 1998. Populational heritability empirical studies of evolution in metapopulations. Am. Nat. 151:135-47
158. Wakeley J, Hey J. 1997. Estimating ancestral population parameters. Genetics 145:847-55
159. Wang DG, Fan JB, Siao CJ, Berno A, Young P, et al. 1998. Large-scale identification, mapping, and genotyping of single-nucleotide polymorphisms in the human genome. Science 280:1077-82
160. Weisgraber KH, Mahley RW. 1996. Human apolipoprotein E: the Alzheimer's disease connection. FASEB J. 10:1485-94
161. Weiss KM. 1993. Genetic Variation and Human Disease:Principles and Evolutionary Approaches. Cambridge, UK: Cambridge Univ. Press. 354 pp.
162. West WL, Knight EM, Pradhan S, Hinds TS. 1997. Interpatient variability:genetic predisposition and other genetic factors. J. Clin. Pharmacol. 37:635-48
163. Whitlock MC, Phillips PC, Wade MJ. 1993. Gene interaction affects the additive genetic variance in subdivided populations with migration and extinction. Evol. 47:1758-69
164. Wright S. 1932. The roles of mutation, inbreeding, crossbreeding, and selection in evolution. Proc. Sixth Int. Cong. Genet 1:356-66
165. Wright S. 1934. Physiological and evolutionary theories of dominance. Am. Nat. 68:25-53
166. Wu WR, Li WM. 1994. A new approach for mapping quantitative trait loci using complete genetic marker linkage maps. Theor. Appl. Genet. 89:535-39
167. Yang AS, Gonzalgo ML, Zingg JM, Millar RP, Buckley JD, et al. 1996. The rate of CpG mutation in Alu repetitive elements within the p53 tumor suppressor gene in the primate germline. J. Mol. Biol. 258:240-50
168. Zerba KE, Ferrell RE, Sing CF. 1998. Genetic structure of five susceptibility gene regions for coronary artery disease:disequilibria within and among regions. Hum. Genet. 103:346-54
169. Zerba KE, Kessling AM, Davignon J, Sing CF. 1991. Genetic structure and the search for genotype-phenotype relationships: an example from disequilibrium in the Apo B gene region. Genetics 129:525-33